Basics Replimune Group, Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $698.21M Activated in VL: True Average Daily Range Avg Daily Range: $0.56 | 3.22% Avg Daily Range (30 D): $0.19 | 4.01% Avg Daily Range (90 D): $0.26 | 4.28% Institutional Daily Volume Avg Daily Volume: .73M Avg Daily Volume (30 D): 6.71M Avg Daily Volume (90 D): 7.75M Trade Size Avg Trade Size (Sh.): 102 Avg Trade Size (Sh.) (30 D): 143 Avg Trade Size (Sh.) (90 D): 150 Institutional Trades Total Inst.Trades: 2,173 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $1.18M Avg Inst. Trade (90 D): $1.42M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.79M Avg Closing Trade (30 D): $1.36M Avg Closing Trade (90 D): $1.87M Avg Closing Volume: 124.23K     News Oct 20, 2025 @ 8:10 PM Why Replimune Stock Was Soaring Today Source: Eric Volkman Oct 20, 2025 @ 11:00 AM Replimune Announces FDA Acceptance of BLA Resubmis... Source: Sushil Patel, Ph.D., Ceo Of Replimune Oct 19, 2025 @ 12:00 PM Replimune Highlights Acral Melanoma Data for RP1 p... Source: Replimune Group, Inc. Sep 21, 2025 @ 3:20 PM REPL FINAL DEADLINE ALERT: Replimune (REPL) Shares... Source: Hagens Berman Sep 21, 2025 @ 11:40 AM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investiga... Source: James (Josh) Wilson Financials   TTM Q1 2026 Q4 2025 Basic EPS $-3.24 $-.95 $-.82 Diluted EPS $-3.24 $-.95 $-.82 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -280.22M $ -86.69M $ -74.13M Operating Income / Loss $ -294.69M $ -90.42M $ -79.33M Cost of Revenue $ $ $ Net Cash Flow $ -54.28M $ -13.74M $ -61.12M PE Ratio     Splits Dec 01, 2010:   15:1